

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin filament depolymerization (GO:0030042) | 9.81750775 |
| 2 | collecting duct development (GO:0072044) | 9.36165815 |
| 3 | drug transport (GO:0015893) | 9.25533535 |
| 4 | organic cation transport (GO:0015695) | 8.90059817 |
| 5 | lysine catabolic process (GO:0006554) | 8.61870855 |
| 6 | lysine metabolic process (GO:0006553) | 8.61870855 |
| 7 | cardiovascular system development (GO:0072358) | 8.21733040 |
| 8 | quaternary ammonium group transport (GO:0015697) | 7.35373057 |
| 9 | glyoxylate metabolic process (GO:0046487) | 7.33274377 |
| 10 | drug catabolic process (GO:0042737) | 7.26191598 |
| 11 | exogenous drug catabolic process (GO:0042738) | 7.21664676 |
| 12 | phosphate ion transmembrane transport (GO:0035435) | 7.03191260 |
| 13 | response to water (GO:0009415) | 6.97064514 |
| 14 | positive regulation of catenin import into nucleus (GO:0035413) | 6.64618193 |
| 15 | cell volume homeostasis (GO:0006884) | 6.55723770 |
| 16 | cysteine metabolic process (GO:0006534) | 6.55713831 |
| 17 | * phosphate ion transport (GO:0006817) | 6.45633202 |
| 18 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 6.43828962 |
| 19 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 6.34287812 |
| 20 | excretion (GO:0007588) | 6.25560639 |
| 21 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 6.06369421 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 6.00558067 |
| 23 | negative regulation of sterol transport (GO:0032372) | 6.00558067 |
| 24 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.88818861 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 5.84666094 |
| 26 | aspartate family amino acid catabolic process (GO:0009068) | 5.82248059 |
| 27 | renal absorption (GO:0070293) | 5.77510464 |
| 28 | vitamin D metabolic process (GO:0042359) | 5.70905920 |
| 29 | toxin transport (GO:1901998) | 5.51746751 |
| 30 | branched-chain amino acid metabolic process (GO:0009081) | 5.49374696 |
| 31 | metanephric tubule development (GO:0072170) | 5.44905562 |
| 32 | metanephric nephron tubule development (GO:0072234) | 5.44905562 |
| 33 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 5.42064435 |
| 34 | negative regulation of metanephros development (GO:0072217) | 5.36042286 |
| 35 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.34462942 |
| 36 | nephron tubule formation (GO:0072079) | 5.33292907 |
| 37 | carnitine transport (GO:0015879) | 5.24961766 |
| 38 | amino-acid betaine transport (GO:0015838) | 5.24961766 |
| 39 | homocysteine metabolic process (GO:0050667) | 5.24844186 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.24401508 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 5.24401508 |
| 42 | glutathione biosynthetic process (GO:0006750) | 5.22333927 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.17449395 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.17039480 |
| 45 | L-phenylalanine catabolic process (GO:0006559) | 5.17039480 |
| 46 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.10091948 |
| 47 | proline metabolic process (GO:0006560) | 5.09128889 |
| 48 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.08762120 |
| 49 | valine metabolic process (GO:0006573) | 5.07524855 |
| 50 | hyperosmotic response (GO:0006972) | 5.02773627 |
| 51 | metanephric nephron epithelium development (GO:0072243) | 5.01989257 |
| 52 | aromatic amino acid family catabolic process (GO:0009074) | 5.01137033 |
| 53 | modified amino acid transport (GO:0072337) | 4.98410754 |
| 54 | serine family amino acid catabolic process (GO:0009071) | 4.97848409 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 4.89791872 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 4.81556097 |
| 57 | tryptophan catabolic process (GO:0006569) | 4.78458020 |
| 58 | indole-containing compound catabolic process (GO:0042436) | 4.78458020 |
| 59 | indolalkylamine catabolic process (GO:0046218) | 4.78458020 |
| 60 | metanephric epithelium development (GO:0072207) | 4.61610920 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 4.59083489 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 4.56668893 |
| 63 | fructose metabolic process (GO:0006000) | 4.56533382 |
| 64 | tryptophan metabolic process (GO:0006568) | 4.56340379 |
| 65 | response to copper ion (GO:0046688) | 4.55850220 |
| 66 | regulation of protein localization to cell surface (GO:2000008) | 4.55762699 |
| 67 | renal system process (GO:0003014) | 4.53252327 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 4.52259866 |
| 69 | branched-chain amino acid catabolic process (GO:0009083) | 4.49004293 |
| 70 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.39491671 |
| 71 | nephron tubule development (GO:0072080) | 4.30962097 |
| 72 | * tricarboxylic acid metabolic process (GO:0072350) | 4.30156818 |
| 73 | peptide biosynthetic process (GO:0043043) | 4.24292101 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 4.22421464 |
| 75 | glomerular visceral epithelial cell development (GO:0072015) | 4.19921917 |
| 76 | inositol metabolic process (GO:0006020) | 4.18538534 |
| 77 | fatty acid oxidation (GO:0019395) | 4.17970004 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 4.14491407 |
| 79 | L-methionine salvage (GO:0071267) | 4.13115605 |
| 80 | L-methionine biosynthetic process (GO:0071265) | 4.13115605 |
| 81 | amino acid salvage (GO:0043102) | 4.13115605 |
| 82 | carnitine metabolic process (GO:0009437) | 4.12427624 |
| 83 | lipid oxidation (GO:0034440) | 4.10099273 |
| 84 | NADH metabolic process (GO:0006734) | 4.07695174 |
| 85 | pattern specification involved in kidney development (GO:0061004) | 4.07575822 |
| 86 | S-adenosylmethionine metabolic process (GO:0046500) | 4.05562379 |
| 87 | peptide catabolic process (GO:0043171) | 4.02434739 |
| 88 | mammary gland alveolus development (GO:0060749) | 4.01599500 |
| 89 | ERK1 and ERK2 cascade (GO:0070371) | 4.01034699 |
| 90 | oligosaccharide catabolic process (GO:0009313) | 3.95912755 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.95229273 |
| 92 | sodium-independent organic anion transport (GO:0043252) | 3.94645472 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.94625502 |
| 94 | glutamate metabolic process (GO:0006536) | 3.93366591 |
| 95 | response to salt stress (GO:0009651) | 3.88522749 |
| 96 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.86121520 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.83047094 |
| 98 | cell differentiation involved in metanephros development (GO:0072202) | 3.82663295 |
| 99 | protein depolymerization (GO:0051261) | 3.82298421 |
| 100 | renal tubule development (GO:0061326) | 3.82223821 |
| 101 | glutathione metabolic process (GO:0006749) | 3.81470555 |
| 102 | * response to mercury ion (GO:0046689) | 3.76651746 |
| 103 | vitamin transport (GO:0051180) | 3.74249783 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.73576068 |
| 105 | response to phenylpropanoid (GO:0080184) | 3.71955225 |
| 106 | aromatic amino acid family metabolic process (GO:0009072) | 3.71786974 |
| 107 | glomerular epithelial cell development (GO:0072310) | 3.68489507 |
| 108 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.67138517 |
| 109 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.66028235 |
| 110 | regulation of catenin import into nucleus (GO:0035412) | 3.62787807 |
| 111 | drug metabolic process (GO:0017144) | 3.61440732 |
| 112 | beta-amyloid metabolic process (GO:0050435) | 3.59318085 |
| 113 | organic acid catabolic process (GO:0016054) | 3.58213449 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.58213449 |
| 115 | ketone body metabolic process (GO:1902224) | 3.56571070 |
| 116 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.56347261 |
| 117 | nephron epithelium morphogenesis (GO:0072088) | 3.56121373 |
| 118 | nephron tubule morphogenesis (GO:0072078) | 3.56121373 |
| 119 | glutathione derivative biosynthetic process (GO:1901687) | 3.54452969 |
| 120 | glutathione derivative metabolic process (GO:1901685) | 3.54452969 |
| 121 | monocarboxylic acid catabolic process (GO:0072329) | 3.54305880 |
| 122 | mesonephros development (GO:0001823) | 3.53753543 |
| 123 | sulfur amino acid catabolic process (GO:0000098) | 3.53599314 |
| 124 | tricarboxylic acid cycle (GO:0006099) | 3.52787812 |
| 125 | regulation of cholesterol efflux (GO:0010874) | 3.51822121 |
| 126 | polyol transport (GO:0015791) | 3.50215104 |
| 127 | nephron epithelium development (GO:0072009) | 3.50066484 |
| 128 | sulfur compound transport (GO:0072348) | 3.48127992 |
| 129 | kynurenine metabolic process (GO:0070189) | 3.45804283 |
| 130 | regulation of fever generation (GO:0031620) | 3.45666758 |
| 131 | dicarboxylic acid metabolic process (GO:0043648) | 3.43725193 |
| 132 | cellular response to vitamin D (GO:0071305) | 3.42628918 |
| 133 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.42006685 |
| 134 | succinate metabolic process (GO:0006105) | 3.40762161 |
| 135 | polyol catabolic process (GO:0046174) | 3.38688579 |
| 136 | response to lithium ion (GO:0010226) | 3.38175439 |
| 137 | indolalkylamine metabolic process (GO:0006586) | 3.38005137 |
| 138 | biotin metabolic process (GO:0006768) | 3.35999965 |
| 139 | benzene-containing compound metabolic process (GO:0042537) | 3.32857613 |
| 140 | glutamine family amino acid catabolic process (GO:0009065) | 3.31544963 |
| 141 | glycine metabolic process (GO:0006544) | 3.31244079 |
| 142 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.30646005 |
| 143 | positive regulation of heat generation (GO:0031652) | 3.30077207 |
| 144 | glucuronate metabolic process (GO:0019585) | 3.29270606 |
| 145 | uronic acid metabolic process (GO:0006063) | 3.29270606 |
| 146 | urogenital system development (GO:0001655) | 3.27409527 |
| 147 | sulfur amino acid biosynthetic process (GO:0000097) | 3.26288319 |
| 148 | chloride transmembrane transport (GO:1902476) | 3.24925121 |
| 149 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.24621600 |
| 150 | inorganic anion transmembrane transport (GO:0098661) | 3.24581462 |
| 151 | methionine biosynthetic process (GO:0009086) | 3.23379586 |
| 152 | regulation of stem cell maintenance (GO:2000036) | 3.22224102 |
| 153 | sodium ion homeostasis (GO:0055078) | 3.17807508 |
| 154 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.16583002 |
| 155 | regulation of plasminogen activation (GO:0010755) | 3.11955654 |
| 156 | negative regulation of kidney development (GO:0090185) | 3.10371954 |
| 157 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.06573850 |
| 158 | epoxygenase P450 pathway (GO:0019373) | 3.04026812 |
| 159 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.03239330 |
| 160 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.03239330 |
| 161 | chloride transport (GO:0006821) | 3.01145293 |
| 162 | flavonoid metabolic process (GO:0009812) | 2.91900355 |
| 163 | regulation of calcium ion import (GO:0090279) | 2.89860710 |
| 164 | * sodium ion transport (GO:0006814) | 2.88839685 |
| 165 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.87519758 |
| 166 | methionine metabolic process (GO:0006555) | 2.87505265 |
| 167 | * inorganic anion transport (GO:0015698) | 2.83235266 |
| 168 | kidney epithelium development (GO:0072073) | 2.82199239 |
| 169 | histamine transport (GO:0051608) | 2.81532481 |
| 170 | negative regulation of lipid transport (GO:0032369) | 2.76692410 |
| 171 | urate metabolic process (GO:0046415) | 11.1153703 |
| 172 | drug transmembrane transport (GO:0006855) | 10.9721127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.50895439 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.41199829 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 5.25953235 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.52762512 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34803424 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91451218 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.76302551 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.27196537 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.88846929 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.87185748 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.67802369 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61691527 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.57646440 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.52388387 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.44419012 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.37750096 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.33694396 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.25598448 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.21189361 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20289806 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16844526 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.14199959 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87767220 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78654635 |
| 25 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77344732 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76399415 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.73334990 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.68009660 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64574791 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63105692 |
| 31 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.62397591 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.60691316 |
| 33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.59628869 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53264606 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51751570 |
| 36 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.50505508 |
| 37 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.49910894 |
| 38 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.49686949 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48475532 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44491183 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43779705 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43714347 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41542029 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38680796 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37823814 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37524651 |
| 47 | CBP_21632823_ChIP-Seq_H3396_Human | 1.37002124 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35798685 |
| 49 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.35630604 |
| 50 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.33467753 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32492071 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31868587 |
| 53 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.31214725 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.30515126 |
| 55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25874193 |
| 56 | KDM2B_26808549_Chip-Seq_REH_Human | 1.25579612 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25425707 |
| 58 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25095587 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24558434 |
| 60 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.22559062 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21812495 |
| 62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21580591 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21327170 |
| 64 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21312626 |
| 65 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.20402732 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19469413 |
| 67 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19057397 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18452469 |
| 69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18452469 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17759315 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16715352 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16242289 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.15922062 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14930353 |
| 75 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.13692722 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12751558 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10892773 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10451492 |
| 79 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.09686162 |
| 80 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.09102672 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08694028 |
| 82 | NFYA_21822215_ChIP-Seq_K562_Human | 1.08276976 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07668065 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06617778 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06375619 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05763036 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03881135 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03459164 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03316235 |
| 90 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02380780 |
| 91 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02380780 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01990173 |
| 93 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01844927 |
| 94 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01726415 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01271179 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00233258 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99661102 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99420267 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98629721 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98286455 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98206664 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97454527 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97431434 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97378228 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96930679 |
| 106 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96508920 |
| 107 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96397006 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96111930 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93668383 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93101619 |
| 111 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93083057 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92535296 |
| 113 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92516621 |
| 114 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.92250466 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92167759 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92039999 |
| 117 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91356537 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91133953 |
| 119 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90431202 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89787672 |
| 121 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.89637408 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89419104 |
| 123 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89343136 |
| 124 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88678616 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.88364581 |
| 126 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.88089787 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87876649 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87662887 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87508841 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87470676 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86088989 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85550028 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85417123 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85381724 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84377040 |
| 136 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.83417433 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82197707 |
| 138 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.81852641 |
| 139 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81729468 |
| 140 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80730021 |
| 141 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.79330330 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79268256 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77393224 |
| 144 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76794390 |
| 145 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75005611 |
| 146 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74766853 |
| 147 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.73533944 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.72657889 |
| 149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72531781 |
| 150 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.71755712 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70989452 |
| 152 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70035046 |
| 153 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69962219 |
| 154 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69953742 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.69847429 |
| 156 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69160980 |
| 157 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69076935 |
| 158 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.68404731 |
| 159 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.67062790 |
| 160 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66972157 |
| 161 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.66746402 |
| 162 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66279767 |
| 163 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66214074 |
| 164 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.65170609 |
| 165 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.65080658 |
| 166 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.64742804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.89952717 |
| 2 | MP0004043_abnormal_pH_regulation | 6.87664338 |
| 3 | MP0005332_abnormal_amino_acid | 5.11922001 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.88941190 |
| 5 | * MP0004019_abnormal_vitamin_homeostasis | 4.21695853 |
| 6 | MP0003195_calcinosis | 4.13867616 |
| 7 | * MP0009643_abnormal_urine_homeostasis | 3.94599459 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.86056277 |
| 9 | * MP0001765_abnormal_ion_homeostasis | 3.72592880 |
| 10 | MP0001756_abnormal_urination | 3.22278784 |
| 11 | * MP0005636_abnormal_mineral_homeostasis | 3.04933502 |
| 12 | * MP0002136_abnormal_kidney_physiology | 2.95151881 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.94866027 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.94528613 |
| 15 | MP0003878_abnormal_ear_physiology | 2.94528613 |
| 16 | MP0001958_emphysema | 2.75665693 |
| 17 | MP0003252_abnormal_bile_duct | 2.44129739 |
| 18 | MP0005365_abnormal_bile_salt | 2.22467575 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.20127254 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.13688548 |
| 21 | MP0001270_distended_abdomen | 1.89443534 |
| 22 | MP0003186_abnormal_redox_activity | 1.89225472 |
| 23 | MP0004885_abnormal_endolymph | 1.87743728 |
| 24 | MP0008961_abnormal_basal_metabolism | 1.82061680 |
| 25 | MP0000538_abnormal_urinary_bladder | 1.71152106 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70364988 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.63460660 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.43689040 |
| 29 | MP0005451_abnormal_body_composition | 1.41587655 |
| 30 | MP0003045_fibrosis | 1.40706635 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.35290318 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.34900390 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.32394982 |
| 34 | MP0000230_abnormal_systemic_arterial | 1.28226852 |
| 35 | MP0002168_other_aberrant_phenotype | 1.28224304 |
| 36 | MP0002928_abnormal_bile_duct | 1.27888848 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.23086028 |
| 38 | MP0005670_abnormal_white_adipose | 1.19417883 |
| 39 | * MP0005319_abnormal_enzyme/_coenzyme | 1.18645456 |
| 40 | MP0002135_abnormal_kidney_morphology | 1.14762471 |
| 41 | MP0005535_abnormal_body_temperature | 1.08874827 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.05743536 |
| 43 | MP0004147_increased_porphyrin_level | 1.05516722 |
| 44 | MP0001764_abnormal_homeostasis | 1.01361034 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 0.96430091 |
| 46 | MP0003283_abnormal_digestive_organ | 0.91069981 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 0.90354783 |
| 48 | MP0003172_abnormal_lysosome_physiology | 0.90138554 |
| 49 | MP0001666_abnormal_nutrient_absorption | 0.87551783 |
| 50 | MP0008872_abnormal_physiological_respon | 0.82826444 |
| 51 | MP0003646_muscle_fatigue | 0.81443731 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 0.80624503 |
| 53 | MP0003638_abnormal_response/metabolism_ | 0.80617388 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 0.78794960 |
| 55 | * MP0009642_abnormal_blood_homeostasis | 0.76178399 |
| 56 | MP0009764_decreased_sensitivity_to | 0.75514339 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 0.67832422 |
| 58 | MP0001485_abnormal_pinna_reflex | 0.67528772 |
| 59 | MP0001661_extended_life_span | 0.67519544 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.64711901 |
| 61 | MP0000371_diluted_coat_color | 0.64196222 |
| 62 | * MP0002896_abnormal_bone_mineralization | 0.63758877 |
| 63 | MP0000609_abnormal_liver_physiology | 0.63611987 |
| 64 | MP0005395_other_phenotype | 0.63212382 |
| 65 | MP0010329_abnormal_lipoprotein_level | 0.62808556 |
| 66 | MP0001191_abnormal_skin_condition | 0.62389522 |
| 67 | MP0002796_impaired_skin_barrier | 0.61476632 |
| 68 | MP0003959_abnormal_lean_body | 0.58285641 |
| 69 | MP0004742_abnormal_vestibular_system | 0.56445779 |
| 70 | MP0003329_amyloid_beta_deposits | 0.56158454 |
| 71 | MP0005408_hypopigmentation | 0.56102697 |
| 72 | MP0003879_abnormal_hair_cell | 0.54282826 |
| 73 | MP0000598_abnormal_liver_morphology | 0.53644327 |
| 74 | MP0005165_increased_susceptibility_to | 0.51617046 |
| 75 | MP0000678_abnormal_parathyroid_gland | 0.50617697 |
| 76 | MP0003941_abnormal_skin_development | 0.50488370 |
| 77 | MP0001944_abnormal_pancreas_morphology | 0.49902947 |
| 78 | MP0005501_abnormal_skin_physiology | 0.49523884 |
| 79 | MP0000026_abnormal_inner_ear | 0.49329531 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.49279741 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.49217770 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 0.49207183 |
| 83 | MP0004858_abnormal_nervous_system | 0.48126255 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.47460639 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.46312744 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.45689745 |
| 87 | * MP0008469_abnormal_protein_level | 0.45414458 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.44052690 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.43619471 |
| 90 | MP0004484_altered_response_of | 0.43555783 |
| 91 | MP0001663_abnormal_digestive_system | 0.43126566 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42349108 |
| 93 | * MP0002115_abnormal_skeleton_extremities | 0.40511256 |
| 94 | MP0004272_abnormal_basement_membrane | 0.39816378 |
| 95 | * MP0003953_abnormal_hormone_level | 0.39603128 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.37734743 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.36064145 |
| 98 | * MP0002069_abnormal_eating/drinking_beha | 0.35708929 |
| 99 | * MP0003795_abnormal_bone_structure | 0.35273847 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.34884744 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.34559526 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.33887971 |
| 103 | MP0000534_abnormal_ureter_morphology | 0.33847980 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.33205014 |
| 105 | MP0005410_abnormal_fertilization | 0.32462368 |
| 106 | MP0003724_increased_susceptibility_to | 0.31163447 |
| 107 | MP0003075_altered_response_to | 0.29881432 |
| 108 | MP0002971_abnormal_brown_adipose | 0.29611166 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.29358199 |
| 110 | MP0001177_atelectasis | 0.28179324 |
| 111 | MP0001664_abnormal_digestion | 0.27849521 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.27416962 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.27334213 |
| 114 | MP0005166_decreased_susceptibility_to | 0.26880445 |
| 115 | MP0000566_synostosis | 0.26465413 |
| 116 | MP0003938_abnormal_ear_development | 0.26456166 |
| 117 | * MP0001731_abnormal_postnatal_growth | 0.25914191 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.25365689 |
| 119 | MP0008874_decreased_physiological_sensi | 0.25301195 |
| 120 | MP0002132_abnormal_respiratory_system | 0.24339208 |
| 121 | MP0001486_abnormal_startle_reflex | 0.24119526 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.20609620 |
| 123 | MP0003942_abnormal_urinary_system | 0.20538791 |
| 124 | MP0004233_abnormal_muscle_weight | 0.19464144 |
| 125 | MP0004130_abnormal_muscle_cell | 0.19341603 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.18249743 |
| 127 | MP0005452_abnormal_adipose_tissue | 0.18191469 |
| 128 | MP0000367_abnormal_coat/_hair | 0.17458273 |
| 129 | MP0009115_abnormal_fat_cell | 0.15615288 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.15578776 |
| 131 | MP0000516_abnormal_urinary_system | 0.15490964 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.15490964 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.14570433 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.14466093 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.13525327 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.13509095 |
| 137 | MP0005409_darkened_coat_color | 0.12257116 |
| 138 | MP0003011_delayed_dark_adaptation | 0.12185712 |
| 139 | MP0008004_abnormal_stomach_pH | 0.11783429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.18200092 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.65955771 |
| 3 | Metabolic alkalosis (HP:0200114) | 7.55954820 |
| 4 | Hypomagnesemia (HP:0002917) | 7.08150416 |
| 5 | Gout (HP:0001997) | 7.03665643 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 7.00624912 |
| 7 | Polyuria (HP:0000103) | 6.86618209 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.47162693 |
| 9 | Abnormal urine output (HP:0012590) | 6.41635325 |
| 10 | Abnormality of renal excretion (HP:0011036) | 6.12505151 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 6.00819768 |
| 12 | Abnormal drinking behavior (HP:0030082) | 5.59226014 |
| 13 | Polydipsia (HP:0001959) | 5.59226014 |
| 14 | Abnormality of renin-angiotensin system (HP:0000847) | 5.04828243 |
| 15 | Alkalosis (HP:0001948) | 5.03616394 |
| 16 | Increased purine levels (HP:0004368) | 5.02310972 |
| 17 | Hyperuricemia (HP:0002149) | 5.02310972 |
| 18 | Renal salt wasting (HP:0000127) | 4.91812161 |
| 19 | Tetany (HP:0001281) | 4.91749688 |
| 20 | Hyperaldosteronism (HP:0000859) | 4.83306741 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.82624704 |
| 22 | Hyperglycinuria (HP:0003108) | 4.80978068 |
| 23 | Abnormality of purine metabolism (HP:0004352) | 4.47708898 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95265050 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.95265050 |
| 26 | Hypokalemia (HP:0002900) | 3.86511666 |
| 27 | Ketoacidosis (HP:0001993) | 3.66448133 |
| 28 | Renal tubular acidosis (HP:0001947) | 3.65907842 |
| 29 | * Proximal tubulopathy (HP:0000114) | 3.60858524 |
| 30 | * Hypercalciuria (HP:0002150) | 3.36452304 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.33143402 |
| 32 | Delayed epiphyseal ossification (HP:0002663) | 3.29111507 |
| 33 | Ketosis (HP:0001946) | 3.27536490 |
| 34 | Large eyes (HP:0001090) | 3.26982092 |
| 35 | Abnormality of potassium homeostasis (HP:0011042) | 3.26057939 |
| 36 | Hydroxyprolinuria (HP:0003080) | 3.25251516 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 3.25251516 |
| 38 | Nephrocalcinosis (HP:0000121) | 3.04877288 |
| 39 | * Glycosuria (HP:0003076) | 2.85477888 |
| 40 | * Abnormality of urine glucose concentration (HP:0011016) | 2.85477888 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77426554 |
| 42 | Hyperglycinemia (HP:0002154) | 2.73950045 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72627222 |
| 44 | Metaphyseal cupping (HP:0003021) | 2.68304615 |
| 45 | Vascular calcification (HP:0004934) | 2.68139374 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.61536216 |
| 47 | Widely patent fontanelles and sutures (HP:0004492) | 2.54760451 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.52970668 |
| 49 | * Nephrolithiasis (HP:0000787) | 2.52576300 |
| 50 | Abnormality of sodium homeostasis (HP:0010931) | 2.50433025 |
| 51 | Dehydration (HP:0001944) | 2.49737960 |
| 52 | Hyponatremia (HP:0002902) | 2.47946903 |
| 53 | Hyperammonemia (HP:0001987) | 2.44484491 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.39389002 |
| 55 | Abnormality of renal resorption (HP:0011038) | 2.37820340 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.37261519 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37261519 |
| 58 | Vomiting (HP:0002013) | 2.30487839 |
| 59 | Renal tubular dysfunction (HP:0000124) | 2.27679412 |
| 60 | Enlarged kidneys (HP:0000105) | 2.27107098 |
| 61 | Metabolic acidosis (HP:0001942) | 2.26793335 |
| 62 | Thin bony cortex (HP:0002753) | 2.25260126 |
| 63 | * Abnormal urine phosphate concentration (HP:0012599) | 2.23933267 |
| 64 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23170819 |
| 65 | Adrenal overactivity (HP:0002717) | 2.22337507 |
| 66 | * Hyperphosphaturia (HP:0003109) | 2.20161250 |
| 67 | Malnutrition (HP:0004395) | 2.19590186 |
| 68 | Confusion (HP:0001289) | 2.18874183 |
| 69 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.10550748 |
| 70 | Methylmalonic aciduria (HP:0012120) | 2.07208024 |
| 71 | Abnormal tarsal ossification (HP:0008369) | 2.06924275 |
| 72 | * Hypophosphatemia (HP:0002148) | 2.05520718 |
| 73 | Chondrocalcinosis (HP:0000934) | 2.04700269 |
| 74 | Lethargy (HP:0001254) | 2.03288608 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03112888 |
| 76 | Tubular atrophy (HP:0000092) | 1.98090633 |
| 77 | Lymphangioma (HP:0100764) | 1.98089998 |
| 78 | Abnormality of the costochondral junction (HP:0000919) | 1.98055895 |
| 79 | Tubulointerstitial fibrosis (HP:0005576) | 1.96059699 |
| 80 | Decreased circulating renin level (HP:0003351) | 1.91755069 |
| 81 | Abnormality of Sharpey fibers (HP:0100685) | 1.91598549 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 1.89991586 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87999733 |
| 84 | Nausea (HP:0002018) | 1.83242703 |
| 85 | Irritability (HP:0000737) | 1.82751976 |
| 86 | Metaphyseal irregularity (HP:0003025) | 1.82121102 |
| 87 | Glomerulosclerosis (HP:0000096) | 1.81645805 |
| 88 | Facial shape deformation (HP:0011334) | 1.79775668 |
| 89 | Potter facies (HP:0002009) | 1.79775668 |
| 90 | Bicornuate uterus (HP:0000813) | 1.79240845 |
| 91 | Metaphyseal dysplasia (HP:0100255) | 1.77392744 |
| 92 | Impaired platelet aggregation (HP:0003540) | 1.75093948 |
| 93 | Abnormal platelet function (HP:0011869) | 1.75093948 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 1.71082193 |
| 95 | Hypotension (HP:0002615) | 1.70972809 |
| 96 | Neonatal onset (HP:0003623) | 1.69784658 |
| 97 | Generalized muscle weakness (HP:0003324) | 1.69413734 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.67946443 |
| 99 | Tachypnea (HP:0002789) | 1.67456827 |
| 100 | Axonal loss (HP:0003447) | 1.65199463 |
| 101 | * Abnormal enzyme/coenzyme activity (HP:0012379) | 1.61944323 |
| 102 | Hyperkalemia (HP:0002153) | 1.61175163 |
| 103 | * Rickets (HP:0002748) | 1.61009336 |
| 104 | Abnormality of carpal bone ossification (HP:0006257) | 1.60086063 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.43767609 |
| 106 | Premature birth (HP:0001622) | 1.38319638 |
| 107 | Esophageal varix (HP:0002040) | 1.37356467 |
| 108 | Paresthesia (HP:0003401) | 1.36477510 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 1.36440521 |
| 110 | Small for gestational age (HP:0001518) | 1.20321001 |
| 111 | Tubulointerstitial abnormality (HP:0001969) | 1.09655988 |
| 112 | Intellectual disability, moderate (HP:0002342) | 1.08437141 |
| 113 | Hypothermia (HP:0002045) | 1.03455387 |
| 114 | Polyhydramnios (HP:0001561) | 1.01488807 |
| 115 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.00302639 |
| 116 | Chorioretinal atrophy (HP:0000533) | 0.98395708 |
| 117 | Neonatal death (HP:0003811) | 0.97490101 |
| 118 | Osteomalacia (HP:0002749) | 0.95836942 |
| 119 | Persistence of primary teeth (HP:0006335) | 0.94818005 |
| 120 | Visceral angiomatosis (HP:0100761) | 0.93907957 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 0.92036140 |
| 122 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 0.90899491 |
| 123 | Abnormality of alanine metabolism (HP:0010916) | 0.90899491 |
| 124 | Hyperalaninemia (HP:0003348) | 0.90899491 |
| 125 | Thyroid-stimulating hormone excess (HP:0002925) | 0.90423249 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 0.90021145 |
| 127 | Enlarged epiphyses (HP:0010580) | 0.88193735 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 0.85435534 |
| 129 | Hemangiomatosis (HP:0007461) | 0.83596174 |
| 130 | Abnormality of the fingertips (HP:0001211) | 0.80347541 |
| 131 | Hyperphosphatemia (HP:0002905) | 0.80016558 |
| 132 | * Osteopenia (HP:0000938) | 0.76848971 |
| 133 | Megaloblastic anemia (HP:0001889) | 0.76848949 |
| 134 | Paralysis (HP:0003470) | 0.72450889 |
| 135 | Abnormal foot bone ossification (HP:0010675) | 0.71401464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.53936393 |
| 2 | WNK3 | 7.72298492 |
| 3 | OXSR1 | 7.59720747 |
| 4 | STK39 | 4.86057800 |
| 5 | BCKDK | 2.97117248 |
| 6 | STK38L | 2.34425868 |
| 7 | WNK1 | 2.03155622 |
| 8 | NEK1 | 1.96507398 |
| 9 | PDK4 | 1.92498765 |
| 10 | PDK3 | 1.92498765 |
| 11 | SGK494 | 1.82825582 |
| 12 | SGK223 | 1.82825582 |
| 13 | PDK2 | 1.40466118 |
| 14 | STK38 | 1.28122911 |
| 15 | MST1R | 1.04571513 |
| 16 | MST4 | 1.03933018 |
| 17 | SGK2 | 0.94122530 |
| 18 | FGFR4 | 0.92194201 |
| 19 | LRRK2 | 0.91145015 |
| 20 | SGK3 | 0.90292243 |
| 21 | PINK1 | 0.79023267 |
| 22 | EPHB1 | 0.77556954 |
| 23 | GRK6 | 0.75958076 |
| 24 | GSK3A | 0.73111804 |
| 25 | TIE1 | 0.63126266 |
| 26 | SGK1 | 0.58345561 |
| 27 | MAP3K7 | 0.57553976 |
| 28 | TGFBR2 | 0.55254406 |
| 29 | ACVR1B | 0.55070519 |
| 30 | DYRK1B | 0.54713156 |
| 31 | PTK2 | 0.51973165 |
| 32 | PAK4 | 0.49248889 |
| 33 | ABL2 | 0.47730722 |
| 34 | MAP3K3 | 0.45286044 |
| 35 | PRKAA1 | 0.45163754 |
| 36 | PDPK1 | 0.43244777 |
| 37 | MAPK11 | 0.42490119 |
| 38 | ERN1 | 0.42300081 |
| 39 | PTK6 | 0.39805234 |
| 40 | TRIB3 | 0.39401674 |
| 41 | JAK3 | 0.37738131 |
| 42 | PAK3 | 0.32739358 |
| 43 | PRKAA2 | 0.32464556 |
| 44 | INSRR | 0.32133706 |
| 45 | FGR | 0.31271685 |
| 46 | PRKCI | 0.30845815 |
| 47 | PRKD2 | 0.30344655 |
| 48 | MET | 0.29556292 |
| 49 | STK10 | 0.29546102 |
| 50 | PTK2B | 0.29313107 |
| 51 | PDK1 | 0.29225569 |
| 52 | NME2 | 0.28804157 |
| 53 | FER | 0.28200926 |
| 54 | PRKCZ | 0.25974753 |
| 55 | NTRK1 | 0.25354236 |
| 56 | STK11 | 0.24089828 |
| 57 | RIPK1 | 0.23831961 |
| 58 | MAP4K1 | 0.23237707 |
| 59 | CDK9 | 0.22830327 |
| 60 | MYLK | 0.22547043 |
| 61 | NTRK3 | 0.22378671 |
| 62 | IRAK2 | 0.20199030 |
| 63 | PRKCD | 0.18674136 |
| 64 | PRKACG | 0.17793037 |
| 65 | MAP3K2 | 0.17210625 |
| 66 | PRKCH | 0.16713184 |
| 67 | MAPK15 | 0.15704317 |
| 68 | RPS6KB2 | 0.15680401 |
| 69 | LATS1 | 0.14757546 |
| 70 | MINK1 | 0.13616632 |
| 71 | FRK | 0.13488021 |
| 72 | ADRBK2 | 0.13440296 |
| 73 | AKT2 | 0.12857863 |
| 74 | MAP3K14 | 0.12363856 |
| 75 | TESK1 | 0.12292027 |
| 76 | MAP2K3 | 0.12136906 |
| 77 | EPHA4 | 0.11826517 |
| 78 | BMX | 0.11420970 |
| 79 | PRKCA | 0.10721900 |
| 80 | ERBB4 | 0.10587257 |
| 81 | CDK12 | 0.10531401 |
| 82 | PIM1 | 0.10425690 |
| 83 | SCYL2 | 0.10161867 |
| 84 | PRKACA | 0.09712708 |
| 85 | MAP2K1 | 0.09701297 |
| 86 | JAK2 | 0.09535783 |
| 87 | MAPK12 | 0.08763557 |
| 88 | MAP2K4 | 0.08180683 |
| 89 | DDR2 | 0.07811978 |
| 90 | FGFR3 | 0.07173918 |
| 91 | BTK | 0.06983127 |
| 92 | NTRK2 | 0.06789285 |
| 93 | CDK19 | 0.06124947 |
| 94 | IRAK1 | 0.06068685 |
| 95 | ROCK1 | 0.05811675 |
| 96 | IRAK3 | 0.04673498 |
| 97 | INSR | 0.04332370 |
| 98 | MAP3K11 | 0.03859333 |
| 99 | NEK6 | 0.03561826 |
| 100 | FGFR2 | 0.03268880 |
| 101 | AURKA | 0.03267359 |
| 102 | PRKCB | 0.02852400 |
| 103 | PRKCG | 0.02844866 |
| 104 | STK3 | 0.02673165 |
| 105 | CSF1R | 0.02525094 |
| 106 | SRC | 0.02521715 |
| 107 | KSR2 | 0.02357974 |
| 108 | KDR | 0.02266685 |
| 109 | TXK | 0.02121606 |
| 110 | BRSK2 | 0.01960880 |
| 111 | ADRBK1 | 0.01611115 |
| 112 | RPS6KB1 | 0.01448599 |
| 113 | CSK | 0.00845924 |
| 114 | MTOR | 0.00507660 |
| 115 | MAPK8 | 0.00363841 |
| 116 | CAMK4 | 0.00093961 |
| 117 | CAMK2B | -0.0534074 |
| 118 | TNK2 | -0.0530825 |
| 119 | RET | -0.0525712 |
| 120 | LCK | -0.0494706 |
| 121 | PRKCE | -0.0485663 |
| 122 | ABL1 | -0.0440862 |
| 123 | CCNB1 | -0.0422636 |
| 124 | EGFR | -0.0407314 |
| 125 | SMG1 | -0.0401550 |
| 126 | FYN | -0.0390016 |
| 127 | PIK3CA | -0.0384924 |
| 128 | CAMK1G | -0.0346295 |
| 129 | PIK3CG | -0.0337832 |
| 130 | TAOK1 | -0.0317435 |
| 131 | PDGFRA | -0.0296055 |
| 132 | ITK | -0.0276659 |
| 133 | HIPK2 | -0.0226913 |
| 134 | PRKG2 | -0.0176393 |
| 135 | IGF1R | -0.0169209 |
| 136 | PRKACB | -0.0158768 |
| 137 | CSNK1A1 | -0.0154058 |
| 138 | TRPM7 | -0.0139231 |
| 139 | LMTK2 | -0.0136182 |
| 140 | PRPF4B | -0.0121783 |
| 141 | RPS6KA1 | -0.0118048 |
| 142 | RPS6KA3 | -0.0098809 |
| 143 | MAPK4 | -0.0092799 |
| 144 | AKT3 | -0.0055770 |
| 145 | PRKD3 | -0.0048838 |
| 146 | YES1 | -0.0026821 |
| 147 | SYK | -0.0012345 |
| 148 | PRKCQ | -0.0003672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.74292129 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.70356054 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.50473820 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50371824 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.49120630 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.20625882 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.15901525 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.14979036 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.00414205 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.64113237 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60350254 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.41793206 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41657420 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.32870699 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32037829 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18299395 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13936697 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01319854 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.96782052 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.90068616 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88470519 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72724699 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69914159 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69418912 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.64571178 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.59278382 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58168560 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54676792 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45323093 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29014314 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.26947567 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.24835364 |
| 33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.24719759 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18034992 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17910479 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16663983 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16549626 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16322105 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08700057 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06822327 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05490126 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03712059 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01608917 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00544683 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99365883 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98933155 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97694874 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97180252 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96352107 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96348375 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94225424 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90159964 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89340502 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.88803792 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83839722 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83433987 |
| 57 | Melanoma_Homo sapiens_hsa05218 | 0.76714465 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76214632 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70526948 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70175884 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68229725 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66637407 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66352107 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65063024 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61780663 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.61153476 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60655562 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58719984 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56169555 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55626605 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54533299 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52693655 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52392513 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51964352 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47080872 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46362228 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45090434 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44882989 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42161093 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.42113068 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41989478 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40755989 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.38731545 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.38411706 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37069976 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32482448 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32010446 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.31716938 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30538611 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29908126 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.26290641 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26045429 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25112477 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24432278 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23182978 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22438206 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.22269204 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22086776 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20378673 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18345640 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17691791 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17076643 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16363200 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14528184 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13751842 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12770202 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11745650 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.11181980 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.10809262 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10058700 |
| 111 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.08299259 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08289083 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07895040 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.07760810 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.07651032 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07060486 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.06877724 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01249650 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.00076469 |
| 120 | Phagosome_Homo sapiens_hsa04145 | -0.0928074 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0706228 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0524248 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | -0.0365297 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0338935 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0233483 |

